Uremic bleeding: Closing the circle after 30 years of controversies?

Blood

Volumn 94, Issue 8, 1999, Pages 2569-2574

  Noris, Marina ^a   Remuzzi, Giuseppe ^b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GUANIDINOSUCCINIC ACID; NITRIC OXIDE;

ARTICLE; BLEEDING; BLEEDING TIME; BLOOD VESSEL TONE; CELL INTERACTION; DETOXIFICATION; DIALYSIS; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; UREA CYCLE; UREMIA;

EID: 0032857219     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.8.2569.420k13_2569_2574     Document Type: Article

References (66)

1. Morgagni GB: Opera Omnia Ex Typographia Remondiniana. Venezia, Italy, 1764
2. Steiner RW, Coggins C, Carvalho ACA: Bleeding time in uremia: A useful test to assess clinical bleeding. Am J Hematol 7:107, 1979
3. Lewis JH, Zucker MB, Ferguson JH: Bleeding tendency in uremia. Blood 11:1073, 1956
4. Moia M, Mannucci PM, Vizzotto L, Casati S, Cattaneo M, Ponticelli C: Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 2:1227, 1987
5. Remuzzi G: Bleeding in renal failure. Lancet 1:1205, 1988
6. Livio M, Benigni A, Remuzzi G: Coagulation abnormalities in uremia. Semin Nephrol 5:82, 1985
7. Livio M, Marchesi D, Remuzzi G, Gotti E, Mecca G, de Gaetano G: Uraemic bleeding: Role of anaemia and beneficial effect of red cell transfusions. Lancet 2:1013, 1982
8. Deguchi N, Ohigashi T, Tazaki H, Handa M, Ikeda Y: Haemodialysis and platelet activation. Nephrol Dial Transplant 2:40, 1991
9. Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Nieuwenhuis HK, Lopez J, Ordinas A: Platelet activation during hemodialysis measured through exposure of p-selectin: Analysis for flow cytometric and ultrastructural techniques. J Lab Clin Med 124:79, 1994
10. Schmitt GW, Moake JL, Rudy CK, Vicks SL, Hamburger RJ: Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis. Am J Med 83:411, 1987
11. Sreedhara R, Itagaki I, Lynn B, Hakim RM: Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Am J Kidney Dis 25:555, 1995
12. Remuzzi G, Benigni A, Dodesini P, Schieppati A, Gotti E, Livio M, Mecca G, Donati MB, De Gaetano G: Platelet function in patients on maintenance hemodialysis: Depressed or enhanced? Clin Nephrol 17:60, 1982
13. Benigni A, Boccardo P, Galbusera M, Monteagudo J, De Marco L, Remuzzi G, Ruggeri ZM: Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J Kidney Dis 22:668, 1993
14. Di Minno G, Martinez J, McKean M, De La Rosa J, Burke JF, Murphy S: Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med 79:552, 1985
15. Himmelfarb J, Holbrook D, McMonagle E, Ault K: Increased reticulated platelets in dialysis patients. Kidney Int 51:834, 1997
16. Eknoyan G, Brown CH: Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol 1:17, 1981
17. Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, De Gaetano G: Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect. J Clin Invest 71:762, 1983
18. Remuzzi G, Minetti L: Hematological consequences of renal failure, in Brenner BM (ed): The Kidney (ed 6). Philadelphia, PA, Saunders, 1998 (in press)
19. Kazatchkine N, Sultan Y, Caen JP, Bariety J: Bleeding in renal failure: A possible cause. Br Med J 2:612, 1976
20. Remuzzi G, Livio M, Roncaglioni MC, Mecca G, Donati MB, De Gaetano G: Bleeding in renal failure: is von Willebrand factor implicated? Br Med J 2:359, 1977
21. Warrell RP Jr, Hultin MB, Coller BS: Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am J Med 66:226, 1979
22. Remuzzi G, Bertani T, Mecca G, Donati MB, De Gaetano G: Factor VIII-related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times. Br Med J 1:70, 1978
23. Altschuler G, Marcus AJ, Ullman HL: Platelets and platelet phosphatides in uremia. Blood 16:1439, 1960
24. Horowitz HI, Cohen BD, Martinez P, Papayoanou MF: Defective ADP-induced platelet factor 3 activation in uremia. Blood 30:331, 1967
25. Horowitz HI, Stein IM, Cohen BD, White JG: Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med 49:336, 1970
26. Perez G, Rey A, Schiff E: The biosynthesis of guanidinosuccinic acid by perfused rat liver. J Clin Invest 57:807, 1976
27. Cohen BD, Stein IM, Bonas JE: Guanidinosuccinic aciduria in uremia. Am J Med 45:63, 1968
28. Stein IM, Cohen BD, Horowitz HI: Guanidinosuccinic acid: the "X" factor in uremic bleeding? Clin Res 16:397, 1968 (abstr)
29. Horowitz HI, Bronx NY: Uremic toxins and platelet function. Arch Intern Med 126:823, 1970
30. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524, 1987
31. Palmer RMJ, Rees DD, Ashton DS, Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153:1251, 1988
32. Furchgott RF, Zawadski JV: The obligatory role of endothelial cells in the relaxation of smooth muscle by acetylcholine. Nature 288:373, 1980
33. Radomski MW, Palmer RMJ, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057, 1987
34. Radomski MW, Palmer RMJ, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193, 1990
35. Neri I, Marietta M, Piccinini F, Volpe A, Facchinetti F: The L-arginine-nitric oxide system regulates platelet aggregation in pregnancy. J Soc Gynecol Invest 5:192, 1998
36. Marietta M, Facchinetti F, Neri I, Piccinini F, Volpe A, Torelli G: L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release. Thromb Res 88:229, 1997
37. Wang Y, Marsden PA: Nitric oxide synthases: Biochemical and molecular regulation. Curr Opin Nephrol Hyperten 4:12, 1995
38. Hogman M, Frostell C, Arnberg H, Hedenstierna G: Bleeding time prolongation and NO inhalation. Lancet 341:1664, 1993
39. Gries A, Bode C, Peter K, Herr A, Bohrer H, Motsch J, Martin E: Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation 97:1481, 1998
40. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, Corna D, Zoja C, Cavallotti D, Remuzzi G: Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 52:171, 1997
41. Remuzzi G, Perico N, Zoja C, Corna D, Macconi D, Viganò G: Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 86:1768, 1990
42. Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, Creager MA: Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharm 26:339, 1995
43. Bonazzola S, Noris M, Todeschini M, Zappella S, Zoja C, Corna D, Gaspari F, Marchetti G, Remuzzi G: 17β-estradiol fully corrects abnormal primary hemostasis in experimental uremia by effectively limiting vascular endothelial overexpression of nitric oxide forming enzymes. J Am Soc Nephrol 9:3088A, 1998 (abstr)
44. Zoja C, Viganò G, Bergamelli A, Benigni A, De Gaetano G, Remuzzi G: Prolonged bleeding time and increased vascular prostacyclin in rats with chronic renal failure: Effects of conjugated estrogens. J Lab Clin Med 112:380, 1988
45. Liu YK, Kosfeld RE, Marcum SG: Treatment of uraemic bleeding with conjugated oestrogen. Lancet 2:887, 1984
46. Livio M, Mannucci PM, Viganò G, Mingardi G, Lombardi R, Mecca G, Remuzzi G: Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315:731, 1986
47. Zoja C, Noris M, Corna D, Viganò G, Perico N, De Gaetano G, Remuzzi G: L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest 65:479, 1991
48. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G: Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 44:445, 1993
49. Matsumoto A, Hirata Y, Kakoki M, Nagata D, Momomura S-i, Sugimoto T, Tagawa H, Omata M: Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure. Clin Sci 96:67, 1999
50. Madore F, Prud'homme L, Austin JS, Blaise G, Francoeur M, Léveillé M, Prud'homme M, Vinay P: Impact of nitric oxide on blood pressure in hemodialysis patients. Am J Kidney Dis 30:665, 1997
51. Yokokawa K, Kohno M, Yoshikawa J: Nitric oxide mediates the cardiovascular instability of haemodialysis patients. Curr Opin Nephrol Hyperten 5:359, 1996
52. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, Kano H, Horio T, Takeda T, Mandel AK: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 123:35, 1995
53. Martensson L, Hegbrandt J, Thysell H: Generation of nitrate during dialysis as a measure of nitric oxide synthesis. Artif Organs 21:163, 1997
54. Thuraisingham RC, Cramp HA, McMahon AC, Wilkes M, Nott CA, Dodd SM, Yaqoob MM, Cunningham J: Increased superoxide and nitric oxide production results in peroxynitrite formation in uremic vasculature. J Am Soc Nephrol 8:340A, 1997 (abstr)
55. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P, Dayer J-M: Balance between IL-1β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 154:882, 1995
56. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int 37:116, 1990
57. Noris M, Todeschini M, Casiraghi F, Roccatello D, Martina G, Minetti L, Imberti B, Gaspari F, Atti M, Remuzzi G: Effect of acetate, bicarbonate dialysis and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension. Am J Kidney Dis 32:115, 1998
58. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA: Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 33:29, 1988
59. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest 92:2080, 1993
60. Levillain O, Marescau B, de Deyn PP: Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int 47:464, 1995
61. Thomas G, Ramwell PW: Endothelium-derived relaxing factor and the vascular role of guanidino compounds. Transplant Proc 25:2057, 1993
62. Thomas G, Ramwell PW: Identification of guanidino succinate as a putative endogenous source of the endothelium derived relaxing factor. Biochem Biophys Res Commun 183:584, 1992
63. Todeschini M, Noris M, Gaspari F, Imberti B, Remuzzi G: Guanidino succinate stimulates the release of nitric oxide (NO) from cultured endothelial cells: Possible implications for uremic bleeding. J Am Soc Nephrol 9:623A, 1998 (abstr)
64. G-monomethyl L-arginine. J Pharmacol Exp Ther 259:490, 1991
65. Irokawa M, Nishinaga M, Ikeda U, Shinoda Y, Suematsu M, Gouda N, Ishimura Y, Shimada K: Endothelial-derived nitric oxide preserves anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. Atherosclerosis 135:9, 1997
66. Wollny T, Iacoviello L, Buczko W, De Gaetano G, Donati MB: Prolongation of bleeding time by acute hemolysis in rats: A role for nitric oxide. Am J Physiol 272:H2875, 1997